Custom Supplement Formulation and Manufacturing: A Complete Guide for Brands

By Honglan Health | Published and updated September 14, 2026

Custom formulation manufacturing for supplements is the process of turning a brand-specific product concept into a documented, tested formula that can be produced consistently at commercial scale. It goes beyond choosing a stock formula and adding a label. The work may include ingredient selection, dose and dosage-form decisions, bench samples, pilot runs, specifications, testing, packaging, regulatory review, and production transfer.

This guide explains each stage, the commercial variables, and the evidence to request before selecting a manufacturing partner.

What Does Custom Formulation Manufacturing Mean?

Custom formulation means developing a product around a brand's requirements rather than purchasing an unchanged, pre-developed formula. The manufacturer may help translate the brief into an ingredient system, select workable raw-material forms, build a prototype, establish specifications, and transfer the approved product into routine production.

The service may be called custom supplement formulation, contract manufacturing, OEM, or ODM. Because these terms overlap, confirm formula ownership, change approval, data access, and the actual production site. Honglan's OEM and ODM service overview shows how one manufacturer defines these models.

Custom formulation vs. private label or stock formulas

If speed and demand validation are the priority, start by evaluating a white label supplement program. If a specific dose, delivery experience, ingredient combination, or positioning is central to the product, custom development is usually the better fit.

The Complete Custom Supplement Development Process

A reliable project uses stage gates. Each stage should produce a document, decision, or test result before the next payment or production commitment.

The technical transfer is where many custom projects succeed or fail. See the related guide to dietary supplement R&D services for a deeper look at development roles.

Start With a Product Brief and Target Dose

The first deliverable should be a one-page product brief, not a list of trendy ingredients. Define the target user, country of sale, desired benefit, daily serving, dosage form, dietary restrictions, allergens, sensory expectations, packaging, launch quantity, target landed cost, and proposed claims direction.

State both the desired ingredient dose and maximum serving burden. A paper formula may require too many capsules, an oversized tablet, an impractical scoop, or more gummy mass than the serving allows. Also distinguish non-negotiable requirements from preferences so the formulator can solve feasibility problems without changing the product's purpose.

Select Ingredients for Feasibility, Not Only Label Appeal

Ingredient selection must account for identity, grade, source, allergens, dose, analytical method, supply, and manufacturing behavior. Materials with the same common name may perform differently across dosage forms.

Ask why each ingredient form was selected, whether the dose fits the serving, which excipients are required, which substitutions are allowed, how specifications will be verified, and whether ingredient status creates a target-market regulatory question.

For the United States, a potential new dietary ingredient needs a specific assessment. A qualifying notification must be submitted at least 75 days before interstate marketing, but this is not automatic for every formula. See the FDA NDI notification guidance and obtain qualified advice when ingredient history is uncertain.

Choose the Dosage Form Around the Formula

The best dosage form is the one that can deliver the required dose, remain stable, provide an acceptable user experience, and run consistently on commercial equipment.

Explore format-specific examples in Honglan's gummy, capsule, and powder collections, then request a project-specific feasibility review.

Solve Flavor, Texture, Solubility, and Stability Early

Botanicals, minerals, acids, oils, fibers, and high active loads can change flavor, color, viscosity, texture, powder flow, dissolution, or stability.

A useful sample review needs measurable criteria. Record serving weight, appearance, flavor, texture, mix time, sedimentation, capsule count, tablet dimensions, or dropper delivery as relevant. Keep the approved sample and formula revision as references.

Shelf life should be supported by a stability program for the actual product and package. Temperature, humidity, light, oxygen, moisture, microbial risk, and closure performance can affect the result. Ask how the claimed shelf life will be established.

Use Samples, Pilot Runs, and Scale-Up as Different Gates

A bench sample answers whether a concept is promising. A pilot or engineering batch answers whether the process can transfer to representative equipment. Commercial production answers whether the approved process can be executed and documented at the ordered scale.

Ask whether the pilot represents the commercial process. If equipment or batch size will change, require a scale-up plan covering critical parameters, yield, in-process checks, sampling, and acceptance criteria.

The FDA's dietary supplement cGMP rule requires a written master manufacturing record for each unique formulation and batch size under 21 CFR 111.205. 21 CFR 111.210 lists required content such as component quantities, theoretical yield, packaging, specifications, sampling, and manufacturing instructions. These records connect the approved formula to repeatable production.

Define Testing, Quality Control, and Documentation

Before ordering, agree on tests, methods, laboratory, review authority, and the response to an out-of-specification result.

21 CFR 111.70 requires specifications for components, in-process production, labels and packaging, and finished products. 21 CFR 111.75 addresses testing and examination needed to determine whether specifications are met. A batch production record under 21 CFR 111.260 documents what happened in each batch.

Request a project-specific document list that may include:

• approved formula and revision history;
• ingredient and packaging specifications;
• certificates of analysis and identity-testing records;
• master manufacturing record and relevant batch-record extracts;
• finished-product specification and certificate of analysis;
• test methods, laboratory details, and release authorization;
• deviation, corrective action, stability, and change-control records; and
• lot traceability, retain-sample, complaint, and recall procedures.

Define document access in confidentiality and quality agreements before a problem occurs.

Match Packaging to Product Protection and Shelf Life

Packaging must protect the formula during storage, shipping, and use. Confirm container material, closure, seal, desiccant, light protection, fill quantity, label stock, coding area, serving delivery, and line compatibility. Review custom supplement packaging options before finalizing product MOQ because printed film, cartons, bottles, caps, droppers, or molds can carry separate minimums and lead times.

What Determines MOQ, Lead Time, and Cost?

There is no universal custom supplement MOQ or lead time. The commercial answer depends on the dosage form, equipment batch size, ingredient purchase minimums, cleaning and setup, testing, yield, packaging, artwork readiness, and number of development rounds.

Separate these quantities in every quotation:

1. Development or sample quantity.
2. Pilot or engineering batch quantity.
3. Commercial product MOQ.
4. Packaging component MOQ.
5. Reorder or forecast commitment, if any.

Cost should be itemized where practical. Ingredients, development, pilot work, testing, tooling, packaging, freight, duties, and surplus components can all change landed cost.

Lead time should be presented as dependencies rather than one number. Formula approval, raw-material availability, test-method readiness, packaging artwork, packaging production, pilot approval, commercial scheduling, testing, and freight each have their own clock. Use the guide to supplement manufacturing delays to build a realistic critical path.

Understand FDA and Target-Market Responsibilities

For U.S. sales, dietary supplements are not approved by FDA before marketing. FDA states that companies are responsible for evaluating safety and ensuring their products comply with applicable requirements. See FDA 101: Dietary Supplements.

Dietary supplement manufacturing is subject to 21 CFR Part 111. FDA's food-facility registration Q&A explains how registration requirements apply to dietary supplement facilities. FDA also states that it is not affiliated with private registration businesses. Registration is not an endorsement, certification, or product approval. See FDA's direct clarification on facility registration and private registration services.

When supplements or ingredients are imported into the United States, identify the FSVP importer before shipment. FDA explains that FSVP duties and modified requirements for dietary supplements depend on whether the import is a finished product or component and on the importer's role. A foreign facility's U.S. agent for facility registration is a separate role and should not be assumed to satisfy FSVP obligations. Review the FDA FSVP final rule overview with qualified counsel.

Labels generally need a statement of identity, net quantity, Supplement Facts, ingredient information, and business identification. See FDA's Dietary Supplement Labeling Guide.

Claims need a separate review. Structure or function claims under section 403(r)(6) must be truthful, not misleading, substantiated, and accompanied by applicable disclaimer requirements. The notifying firm must submit the notification to FDA within 30 days after first marketing; FDA silence is not product approval. The FDA structure/function claims page explains the pathway, while the FTC Health Products Compliance Guidance addresses advertising substantiation. Use Honglan's U.S. dietary supplement compliance risk guide for a broader operational checklist.

For EU sales, food supplements are regulated as foods under Directive 2002/46/EC, and Member States may request market notification. Nutrition and health claims must follow Regulation (EC) No 1924/2006 and applicable conditions in the EU Register. An ingredient may also require a novel-food assessment. Confirm the country of sale, formula, claims, and responsible food business operator rather than treating "EU compliant" as a blanket status. Use the European Commission's pages on food supplements, nutrition and health claims, and novel foods as starting points.

How to Choose a Custom Supplement Manufacturer

Use evidence-based pass or fail criteria before comparing price.

Manufacturer evaluation checklist

• Identifies the legal entity and exact production site.
• Shows relevant experience and equipment for the proposed dosage form and batch range.
• Assigns a technical owner who can explain feasibility limits and tradeoffs.
• Uses controlled formulas, specifications, master records, batch records, and change control.
• Defines ingredient qualification, approved substitutions, test methods, and batch release authority.
• Explains what the sample and pilot can prove before scale-up.
• Separates development, product, and packaging minimums.
• Provides a dependency-based schedule and names the project owner.
• States formula ownership, confidentiality, data access, and transfer rights in writing.
• Provides relevant audit, certification, inspection, complaint, and recall evidence for verification.
• Explains label and claims-review boundaries without presenting registration as approval.
• Itemizes major quotation assumptions, exclusions, and landed-cost variables.

Verify each certification's scope, site, validity, and issuing body.

What to Prepare Before Requesting a Quote

For a useful, comparable quotation, prepare:

• target consumer and countries of sale;
• desired benefit and claims direction;
• ingredient list, preferred forms, target doses, and prohibited ingredients;
• serving size and preferred dosage form;
• flavor, sweetener, color, allergen, dietary, and certification requirements;
• target shelf life and storage conditions;
• package type, count, artwork status, and labeling responsibility;
• forecast, launch order, reorder expectations, and target date;
• target unit cost or landed cost; and
• required tests, documents, ownership terms, and approval process.

Mark which items are fixed and which are open to technical recommendations.

Frequently Asked Questions

How long does custom supplement formulation take?

It depends on formula complexity, ingredients, sample revisions, pilot work, testing, packaging, and regulatory review. Request a stage-by-stage schedule with dependencies.

What is the typical MOQ for a custom supplement?

There is no industry-wide MOQ. Batch size, ingredients, cleaning, yield, testing, and packaging affect it. Compare development, pilot, product, and packaging minimums separately.

Can a manufacturer copy a competitor's supplement formula?

A public label can be a reference, but it does not disclose grades, processing, overages, specifications, or proprietary know-how. Develop the product around your own brief and IP review.

Who owns a custom supplement formula?

Ownership depends on the contract. Define rights to the formula, specifications, stability data, tooling, samples, and transfer documents before development.

Does an FDA-registered facility mean the supplement is FDA approved?

No. FDA does not preapprove dietary supplements, and facility registration is not a quality award or approval. Evaluate the site, quality system, records, inspection history, testing, and product-specific compliance work.

When should packaging development begin?

Begin during feasibility, not after formula approval. The package can affect stability, serving delivery, line compatibility, MOQ, lead time, and landed cost.

Request a Custom Formulation Assessment

Honglan's current OEM and ODM page, reviewed September 14, 2026, lists custom development for gummies, hard capsules, softgels, tablets, powders, liquid drops, and pastes. Product, ingredient, and packaging minimums, unit definitions, development scope, testing, and timing should be confirmed in the project quotation.

To receive a useful assessment, send the product brief, target market, dosage form, ingredient and dose requirements, estimated volume, packaging concept, target cost, and launch date. Request a custom formulation assessment and ask the technical team to return feasibility risks, required decisions, sample steps, minimums, testing, and a documented path to commercial production.